Matthew McLean

The Foundry LLC provides investment services to medical device companies. It includes the inventor partners of business development, product development and prototyping, market analysis and development, human resources and recruitment and intellectual property enterprise. The company was founded by Allan R Will and Henry A. Plain, Jr. in 1998 and is headquartered in Menlo Park, CA.

Foundry Innovation & Research 1 Ltd. develops novel therapeutic devices. It has evolved into one of the leading clusters for medical devices globally. The company was headquartered in Dublin, Ireland.

Twelve, Inc. is a holding company, which engages in the operation as an investment fund for a medical device incubator. It specializes on funding and developing medical device inventions. The company focuses on medical and biotech ventures. The company was founded in 2009 and is headquartered in Redwood City, CA.

Foundry Therapeutics 1, Inc. engages in the development of pharmaceutical products. The company is headquartered in Menlo Park, CA.

LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California.

Miramar Technologies, Inc. develops and provides medical devices for dermatologic medical conditions. It specializes in microwave energy positioned to be adopted for dermatologic conditions. The company was founded by Henry A. Plain Jr., Mark E. Deem and Steven Kim in 2006 and is headquartered in Half Moon Bay, CA.

Part of Abbott Laboratories, Vascular Science, Inc. develops suture-free devices to facilitate coronary artery bypass grafting. The company is based in Minneapolis, MN. The company was founded by Daniel J. Sullivan, Simon H. Stertzer, Rudy A. Mazzocchi. Vascular Science was acquired by St. Jude Medical LLC, part of Abbott Laboratories from January 05, 2017 on September 27, 1999 for $100 million.

Reprieve Cardiovascular, Inc. engages in the manufacturing of medical devices. The firm develops device to treat patients suffering from acute decompensated heart failure (ADHF). The company is headquartered in Milford, MA.

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

Tangible Science, Inc. manufactures contact lenses and provides eye care services. It develops a novel polymer based coating technology for use in contact lenses to treat dry eye disease. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Karen Havenstrite, Victor W. McCray, and Garrett Cale Smith in 2011 and is headquartered in Redwood City, CA.

Contego Medical LLC develops novel emboli protection devices. Its products include CORGUARD coronary stent system, VANGUARD renal stent system, and PALADIN carotid post-dilation balloon. The company was founded by Ravish Sachar and Jay S. Yadav in 2005 and is headquartered in Raleigh, NC.

Nuvaira, Inc. develops medical devices for treating lung diseases. It works on a novel catheter-based system that has the potential to improve lung function, exercise capacity and quality of life for patients with chronic obstructive pulmonary disease. The company was founded by Steven Dimmer and Martin L. Mayse in 2008 and is headquartered in Plymouth, MN.

Medical Technology Venture Partners (MedTech Venture Partners) is a venture capital firm founded by Radu Cautis and Thomas Heinrich Glanzmann in 2017. The firm is headquartered in San Francisco, California.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Evalve, Inc. designs, develops, manufactures and markets devices. It developed a proprietary system which enables percutaneous repair of cardiac valves. The firm's products reduces the risks, trauma, and costs associated with current open, arrested heart surgical options. The company was founded on June 9, 1999 and is headquartered in Menlo Park, CA.

Emphasys Medical, Inc., a medical technology company, focuses on developing and commercializing minimally invasive therapeutic devices for the treatment of patients with emphysema and other breathing disorders. It offers Zephyr Endobronchial Valve system, which is designed to block air from passing through the opening in the lung and into the chest cavity, resulting in the reduction or elimination of airflow through the leak to allow the tissue to heal. The company offers its products through distributors and dealers in Europe, Australia, Hong Kong, and Singapore. Emphasys Medical was founded in 2000 and is based in Redwood City, CA. Emphasys Medical, Inc. operates as a subsidiary of Pulmonx Corp.

Qlt Plug Delivery, Inc. provides ocular punctual plug drug delivery system. Its product is used in the treatment of glaucoma. The company was founded by Henry A. Plain Jr. and is headquartered in Menlo Park, CA.

Bavaria Medizin Technologie GmbH engages in design, development, and manufacture of different types of catheters and delivery devices for vascular and non-vascular applications. It offers catheters for coronary, peripheral and cranial indications, dilatation catheters, devices for local drug delivery, stent delivery devices, and ear, nose and throat devices. The company was founded by Hanson S. Gifford, III in 1992 and is headquartered in Wessling, Germany.

Transcend Medical, Inc. operates as a medical device company. It develops medical devices for the treatment of glaucoma, the cause of adult irreversible blindness. The company was founded in 2005 and is headquartered in Lake Forest, CA.

ForSight Labs LLC operates as an ophthalmic technology incubator. It focuses on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. The company was founded by Eugene de Juan, Hanson S. Gifford and Henry A. Plain in 2005 and is headquartered in Menlo Park, CA.

Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA.

ForSight VISION4, Inc. develops novel drug delivery therapies for treatment of retinal diseases. The company was founded on June 26, 009 and is headquartered in Menlo Park, CA.

ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ.

Cala Health, Inc. operates as a bioelectronic medicine company. It develops wearable neuromodulation therapies. The company was founded by Kathryn Rosenbluth, Scott Delp and Serena Wong in 2014 and is headquartered in Burlingame, CA.